Leidos Delivers Strong Third Quarter and Enhances Full-Year Guidance

Leidos Holdings, Inc. (LDOS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Leidos Delivers Strong Third Quarter and Enhances Full-Year Guidance u Revenues of $4.6 billion, up 4% year-over-year u Net income of $413 million or $3.28 per diluted share u Adjusted EBITDA (non-GAAP) of $644 million and Adjusted EBITDA margin (non-GAAP) of 13.9% u

Event · Earnings
Also in this documentGuidance · lower · $18–$18.2Dividend · increase · $0.45

Facts are quoted from the filing text and checked against it. Details that could not be matched to the text are left out.

Original reporting
Published Nov 2, 2026, 10:38 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 11:04 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$LDOS
Bullish
high confidence
Mentioned
$LDOS
Relevance
9/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$LDOSBullishHigh
01

Why it matters

The issued guidance reflects strong demand for defense tech and new contracts, likely supporting a rally in LDOS.

02

Market read

First‑report earnings and guidance raise for a large‑cap defense contractor, creating a clear trading catalyst.

03

What to watch

Potential headwinds from slower health‑IT programs could temper long‑term growth.

Relevance 9/10Novelty 9/10Timing: after‑hours release
AlphAI · Earnings readLDOS · third quarter of fiscal year 2026 · ended October 2, 2026

Leidos Delivers Strong Third Quarter and Enhances Full-Year Guidance

✓Solid quarter

Third-quarter revenue, net income, diluted EPS, adjusted EBITDA and non-GAAP diluted EPS increased year-over-year, Homeland growth and improved profitability supported results, and fiscal 2026 non-GAAP diluted EPS and operating-cash-flow guidance increased. Health revenue and margins declined, quarterly operating cash flow and free cash flow were below the prior-year quarter, and the revenue guidance range was reduced following the SES joint venture adjustment.

Revenue
$4.63B
4% y/y
Intelligence & Digital
$1.55B
1% y/y
Operating margin · non-GAAP
13.1 %
EPS · non-GAAP
$ 3.62
19% y/y
FY26 outlook
$18.00 - $18.20

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Revenue, three months ended October 2, 2026GAAP$4.63B–4%
Operating income, three months ended October 2, 2026GAAP$553M––
Operating income margin, three months ended October 2, 2026GAAP11.9 %––
Net income, three months ended October 2, 2026GAAP$413M–12%
Net income margin, three months ended October 2, 2026GAAP8.9 %––
Net income attributable to Leidos common stockholders, three months ended October 2, 2026GAAP$410M––
Diluted earnings per share, three months ended October 2, 2026GAAP$ 3.28–16%
Basic earnings per share, three months ended October 2, 2026GAAP$ 3.31––
Non-GAAP operating income, three months ended October 2, 2026non-GAAP$607M––
Non-GAAP operating margin, three months ended October 2, 2026non-GAAP13.1 %––
Non-GAAP net income, three months ended October 2, 2026non-GAAP$455M–14%
Non-GAAP diluted EPS, three months ended October 2, 2026non-GAAP$ 3.62–19%
Adjusted EBITDA, three months ended October 2, 2026non-GAAP$644M–5%
Adjusted EBITDA margin, three months ended October 2, 2026non-GAAP13.9 %––
Net cash provided by operating activities, three months ended October 2, 2026GAAP$523M––
Operating cash flow conversion ratio, three months ended October 2, 2026other128 %––
Non-GAAP free cash flow, three months ended October 2, 2026non-GAAP$476M––
Non-GAAP free cash flow conversion ratio, three months ended October 2, 2026non-GAAP105 %––
Net bookings, three months ended October 2, 2026other$5.5B––
Book-to-bill ratio, three months ended October 2, 2026other1.2––
Backlog, October 2, 2026other$49.6B–4%
Funded backlog, October 2, 2026other$11.1B–22%
Revenue, nine months ended October 2, 2026GAAP$13.59B––
Operating income, nine months ended October 2, 2026GAAP$1.57B––
Net income, nine months ended October 2, 2026GAAP$1.10B––
Diluted earnings per share, nine months ended October 2, 2026GAAP$ 8.67––
Non-GAAP diluted EPS, nine months ended October 2, 2026non-GAAP$ 10.03––
Adjusted EBITDA, nine months ended October 2, 2026non-GAAP$1.89B––
Net cash provided by operating activities, nine months ended October 2, 2026GAAP$1.62B––

Segments

SegmentRevenueq/qy/y
Intelligence & DigitalRecent contract awards and higher volumes and expanded scope across key Intelligence Community programs, offset by reductions in certain federal civilian IT programs.$1.55B–1%
HealthExpected program shifts and reduced volumes on managed health services programs.$1.07B–(12%)
HomelandStrong demand for air traffic management and electric power distribution engineering solutions, as well as $142 million from the acquisition of ENTRUST Solutions.$1.02B–32%
DefenseIncreased demand for defense technology areas including air defense, sensing, and C5ISR systems.$992M–3%

FY26 outlook

  • Revenue$18.00 - $18.20
  • NoteAdjusted EBITDA Margin: Mid 13%
  • NoteNon-GAAP Diluted EPS: $12.50 - $12.70
  • NoteCash Flows Provided by Operating Activities (B): Approximately $1.90

Capital returns

  • $556 million returned to shareholders in the quarter, including $504 million in share repurchases and $52 million as part of a regular quarterly cash dividend program.
  • On October 30, 2026, the Board declared a cash dividend of $0.45 per share, an increase of 4.7% over the prior quarter's dividend amount. The dividend is payable on December 31, 2026, to stockholders of record at the close of business on December 15, 2026.
  • Cash dividends declared per share were $ 0.43 for the three months ended October 2, 2026, compared with $ 0.40 for the three months ended October 3, 2025.
  • Repurchases of stock and other were $ 504 million for the three months ended October 2, 2026, compared with $ 102 million for the three months ended October 3, 2025.

What drove it

  • Quarterly revenue grew due to increased customer demand for defense tech products, air traffic management solutions, and intelligence mission support, as well as the acquisition of ENTRUST Solutions.
  • Profitability was driven by improved program performance and disciplined cost management across the portfolio.
  • GAAP and non-GAAP earnings measures reflected a lower effective tax rate, primarily due to an increase in the federal research tax credit and a decrease in unrecognized tax benefits.
  • The October 5, 2026 closing of the Contribution and Equity Purchase Agreement with Altaris contributed the Security Enterprise Solutions and Industrial Automation businesses to a newly formed joint venture.
  • Trailing-twelve-month book-to-bill of 1.1 resulted in year-over-year growth in total and funded backlog of 4% and 22%, respectively.

Concerns

  • Health revenue decreased by 12% and Health operating income margin declined to 22.5% from 26.8%, driven by expected program shifts and reduced volumes on managed health services programs.
  • Quarterly net cash provided by operating activities declined to $ 523 million from $ 711 million, while non-GAAP free cash flow declined to $ 476 million from $ 680 million.
  • FY26 revenue guidance was adjusted to $18.00 - $18.20 from $18.20 - $18.40 after adjusting for the joint venture and incorporating its year-to-date performance and current outlook.
  • Interest expense, net, increased to $ 67 million in the quarter from $ 51 million in the prior-year quarter.
  • Three-month total operating income margin was 11.9 % compared with 12.0 % in the prior-year quarter.

What to watch

  • Execution of the FY26 guidance range of $18.00 - $18.20 in revenue, Mid 13% adjusted EBITDA margin, $12.50 - $12.70 non-GAAP diluted EPS, and Approximately $1.90 cash flows provided by operating activities.
  • Health program shifts, managed health services volumes, and the segment's operating income margin.
  • Contribution of ENTRUST Solutions, which provided $142 million of Homeland acquisition revenues in the quarter.
  • Conversion of the $49.6 billion backlog and $11.1 billion funded backlog into revenue.
  • Performance after the contribution of the SES businesses to the Altaris joint venture.

Balance sheet and cash flow

  • Cash and cash equivalents were $630 million as of October 2, 2026, compared with $ 1,108 million as of January 2, 2026.
  • Debt was $6.0 billion as of October 2, 2026.
  • Net cash used in investing activities was $ 48 million in the quarter, including $ 47 million in payments for property, equipment and software.
  • Net cash used in financing activities was $ 549 million in the quarter, compared with $ 595 million used in the prior-year quarter.
  • Nine-month acquisition of a business, net of cash acquired, was $ 2,338 million, compared with $ 292 million in the prior-year nine-month period.
  • Nine-month net cash used in investing activities was $ 2,445 million, compared with $ 372 million in the prior-year nine-month period.

Analysis

Leidos reported third-quarter revenue of $4.6 billion, up 4% year-over-year, with GAAP net income of $413 million and diluted EPS of $3.28. Non-GAAP diluted EPS increased 19% to $3.62, while adjusted EBITDA rose 5% to $644 million and adjusted EBITDA margin increased to 13.9% from 13.8%. Management attributed revenue growth to demand for defense technology products, air traffic management solutions and intelligence mission support, alongside the ENTRUST Solutions acquisition. Earnings also reflected a lower effective tax rate, primarily from a higher federal research tax credit and lower unrecognized tax benefits.

Segment performance was uneven. Homeland revenue grew 32% to $1.02 billion, including $142 million from ENTRUST Solutions, and its GAAP operating income margin rose to 7.9% from 6.5%; non-GAAP operating margin increased to 11.3% from 7.5%. Intelligence & Digital revenue rose 1% to $1.55 billion and GAAP operating income margin improved to 11.1% from 9.2%. Defense revenue increased 3% to $992 million and margin increased to 8.7% from 8.2%. Health was the offset, with revenue down 12% to $1.07 billion and GAAP operating income margin down to 22.5% from 26.8% because of expected program shifts and reduced managed-health-services volumes.

Cash generation remained positive but was lower than the prior-year quarter. Operating cash flow was $523 million, compared with $711 million, and non-GAAP free cash flow was $476 million, compared with $680 million. Leidos returned $556 million to shareholders during the quarter, including $504 million of share repurchases and $52 million in dividends. Cash and cash equivalents were $630 million and debt was $6.0 billion as of October 2, 2026. The Board declared a $0.45 per-share dividend on October 30, 2026, which the release says is 4.7% above the prior quarter's dividend amount.

Demand indicators were constructive. Quarterly net bookings were $5.5 billion, producing a 1.2 book-to-bill ratio, and backlog was $49.6 billion, including $11.1 billion funded. Trailing-twelve-month book-to-bill of 1.1 supported year-over-year total backlog growth of 4% and funded backlog growth of 22%. Key awards spanned intelligence, air traffic management, defense health, cyber, space sensing and naval systems.

Leidos adjusted FY26 guidance after the October 5 closing of the contribution of its SES businesses to a newly formed joint venture with Altaris. The revenue range moved to $18.00 - $18.20 from $18.20 - $18.40, while adjusted EBITDA margin remained Mid 13%. The non-GAAP diluted EPS range increased to $12.50 - $12.70 from $12.20 - $12.50, and cash flows provided by operating activities increased to Approximately $1.90 from Approximately $1.85. The central reporting issues are the adjusted revenue outlook, sustained Health pressure, the lower quarterly cash flow versus the prior-year period, and whether higher-margin Homeland commercial work and program execution improvements continue to support profitability.

Management, verbatim

Leidos delivered another quarter of strong financial performance, allowing us to enhance our 2026 guidance for the third consecutive quarter.

Tom Bell, Chief Executive Officer

Our sustained momentum reflects the strength of our focused team, united behind our NorthStar 2030 strategy and committed to delivering on our customers’ most critical missions.

Tom Bell, Chief Executive Officer

Not in the filing

stated, not guessed
  • Gross margin was not reported.
  • Gross profit was not reported.
  • Effective tax rate was not reported.
  • Prior-quarter financial metrics were not reported for the third quarter of fiscal 2026.
  • Forward guidance for gross margin, operating expenses and tax rate was not reported.
  • Segment revenue sequential changes were not reported.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. Guided figures in the outlook comparison come from the company’s previous release. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Background

Leidos filed a Form 8‑K on Nov 2 2026 reporting its third‑quarter 2026 results and updating its full‑year outlook.

Company-level read

Ticker impact

$LDOSBullishHigh confidence
Context

Leidos reported Q3 results with revenue of $4.6 B and issued issued guidance for full‑year 2026.

Expected impact

likely upside as investors value the higher revenue and earnings outlook

Evidence & confidence

The earnings beat and issued guidance are fresh primary disclosures for a large‑cap defense contractor, providing a clear catalyst for buying.

Market effects

Strengthens the defense and aerospace sector outlook as Leidos' contracts signal continued government spending.

Positive for U.S. technology and defense stocks.

Reinforces confidence in U.S. defense contractors globally.

Counterpoint

If the raised guidance already priced in, the stock may face short‑term profit‑taking.

Key entities

  • Leidos Holdings, Inc.

    U.S. defense and technology services provider.

Every LDOS earnings report

This story covers one filing. The ticker page keeps them all: each quarter's reported metrics with year-over-year and sequential comparisons, segments, guidance, and how the numbers landed against the company's own prior outlook.

Related articles

$LDOSMed

Leidos wins $40.8m contract for Marine air defense radar

Leidos Holdings (LDOS) won a $40.8M contract to build and support 14 Medium Range Air Defense Radar systems for the U.S. Marine Corps, according to the company. The contract includes options for retrofitting prototypes and existing systems. Work is expected to be completed by August 2028. Leidos reported $17.2B in annual revenue for the fiscal year ended January 2, 2026.

$LDOSMed

Leidos building low-signature air defense for Marines

Leidos (LDOS) received a $40.8M contract to build 14 Medium Range Air Defense Radar (MRADR) systems for the Marines, advancing from prototyping to operational deployment. The mobile systems aim to provide 360-degree surveillance while minimizing detection risk. Work is expected to be completed by August 2028, with options to retrofit existing systems. This aligns with Leidos' NorthStar 2030 strategy, focusing on defense technology.

$LDOSMed

Leidos selected for NASA logistics support contract

Leidos (LDOS) is one of 16 companies selected for NASA’s Enterprise Logistics Support Services program. The contract, valued at $1.4 billion, covers logistics support for NASA missions over five years. Leidos has provided logistics support to NASA for over 20 years, handling cargo for the International Space Station. The company reported $17.2 billion in annual revenue for 2026.